51
|
Sarafidis PA, Loutradis C, Karpetas A, Tzanis G, Piperidou A, Koutroumpas G, Raptis V, Syrgkanis C, Liakopoulos V, Efstratiadis G, London G, Zoccali C. Ambulatory Pulse Wave Velocity Is a Stronger Predictor of Cardiovascular Events and All-Cause Mortality Than Office and Ambulatory Blood Pressure in Hemodialysis Patients. Hypertension 2017; 70:148-157. [PMID: 28483919 DOI: 10.1161/hypertensionaha.117.09023] [Citation(s) in RCA: 80] [Impact Index Per Article: 11.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2017] [Revised: 01/18/2017] [Accepted: 03/04/2017] [Indexed: 12/17/2022]
Abstract
Arterial stiffness and augmentation of aortic blood pressure (BP) measured in office are known cardiovascular risk factors in hemodialysis patients. This study examines the prognostic significance of ambulatory brachial BP, central BP, pulse wave velocity (PWV), and heart rate-adjusted augmentation index [AIx(75)] in this population. A total of 170 hemodialysis patients underwent 48-hour ambulatory monitoring with Mobil-O-Graph-NG during a standard interdialytic interval and followed-up for 28.1±11.2 months. The primary end point was a combination of all-cause death, nonfatal myocardial infarction, and nonfatal stroke. Secondary end points included: (1) all-cause mortality; (2) cardiovascular mortality; and (3) a combination of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, resuscitation after cardiac arrest, coronary revascularization, or hospitalization for heart failure. During follow-up, 37(21.8%) patients died and 46(27.1%) had cardiovascular events. Cumulative freedom from primary end point was similar for quartiles of predialysis-systolic BP (SBP), 48-hour peripheral-SBP, and central-SBP, but was progressively longer for increasing quartiles for 48-hour peripheral-diastolic BP and central-diastolic BP and shorter for increasing quartiles of 48-hour central pulse pressure (83.7%, 71.4%, 69.0%, 62.8% [log-rank P=0.024]), PWV (93.0%, 81.0%, 57.1%, 55.8% [log-rank P<0.001]), and AIx(75) (88.4%, 66.7%, 69.0%, 62.8% [log-rank P=0.014]). The hazard ratios for all-cause mortality, cardiovascular mortality, and the combined outcome were similar for quartiles of predialysis-SBP, 48-hour peripheral-SBP, and central-SBP, but were increasing with higher ambulatory PWV and AIx(75). In multivariate analysis, 48-hour PWV was the only vascular parameter independently associated with the primary end point (hazard ratios, 1.579; 95% confidence intervals, 1.187-2.102). Ambulatory PWV, AIx(75), and central pulse pressure are associated with increased risk of cardiovascular events and mortality, whereas office and ambulatory SBP are not. These findings further support that arterial stiffness is the prominent cardiovascular risk factor in hemodialysis.
Collapse
Affiliation(s)
- Pantelis A Sarafidis
- From the Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Greece (P.A.S., C.L., G.T., A.P., G.E.); Therapeutiki Hemodialysis Unit, Thessaloniki, Greece (A.K.); Hemodialysis Unit, Achillopouleion General Hospital, Volos, Greece (G.K., C.S.); Pieria Hemodialysis Unit, Katerini, Greece (V.R.); Section of Nephrology and Hypertension, 1st Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Greece (V.L.); Manhès Hospital and FCRIN INI-CRCTC, Fleury Mérogis, France (G.L.); and CNR-IFC, Clinical Epidemiology and Pathophysiology of Hypertension and Renal Diseases Unit, Ospedali Riuniti, Reggio Calabria, Italy (C.Z.).
| | - Charalampos Loutradis
- From the Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Greece (P.A.S., C.L., G.T., A.P., G.E.); Therapeutiki Hemodialysis Unit, Thessaloniki, Greece (A.K.); Hemodialysis Unit, Achillopouleion General Hospital, Volos, Greece (G.K., C.S.); Pieria Hemodialysis Unit, Katerini, Greece (V.R.); Section of Nephrology and Hypertension, 1st Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Greece (V.L.); Manhès Hospital and FCRIN INI-CRCTC, Fleury Mérogis, France (G.L.); and CNR-IFC, Clinical Epidemiology and Pathophysiology of Hypertension and Renal Diseases Unit, Ospedali Riuniti, Reggio Calabria, Italy (C.Z.)
| | - Antonios Karpetas
- From the Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Greece (P.A.S., C.L., G.T., A.P., G.E.); Therapeutiki Hemodialysis Unit, Thessaloniki, Greece (A.K.); Hemodialysis Unit, Achillopouleion General Hospital, Volos, Greece (G.K., C.S.); Pieria Hemodialysis Unit, Katerini, Greece (V.R.); Section of Nephrology and Hypertension, 1st Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Greece (V.L.); Manhès Hospital and FCRIN INI-CRCTC, Fleury Mérogis, France (G.L.); and CNR-IFC, Clinical Epidemiology and Pathophysiology of Hypertension and Renal Diseases Unit, Ospedali Riuniti, Reggio Calabria, Italy (C.Z.)
| | - Georgios Tzanis
- From the Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Greece (P.A.S., C.L., G.T., A.P., G.E.); Therapeutiki Hemodialysis Unit, Thessaloniki, Greece (A.K.); Hemodialysis Unit, Achillopouleion General Hospital, Volos, Greece (G.K., C.S.); Pieria Hemodialysis Unit, Katerini, Greece (V.R.); Section of Nephrology and Hypertension, 1st Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Greece (V.L.); Manhès Hospital and FCRIN INI-CRCTC, Fleury Mérogis, France (G.L.); and CNR-IFC, Clinical Epidemiology and Pathophysiology of Hypertension and Renal Diseases Unit, Ospedali Riuniti, Reggio Calabria, Italy (C.Z.)
| | - Alexia Piperidou
- From the Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Greece (P.A.S., C.L., G.T., A.P., G.E.); Therapeutiki Hemodialysis Unit, Thessaloniki, Greece (A.K.); Hemodialysis Unit, Achillopouleion General Hospital, Volos, Greece (G.K., C.S.); Pieria Hemodialysis Unit, Katerini, Greece (V.R.); Section of Nephrology and Hypertension, 1st Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Greece (V.L.); Manhès Hospital and FCRIN INI-CRCTC, Fleury Mérogis, France (G.L.); and CNR-IFC, Clinical Epidemiology and Pathophysiology of Hypertension and Renal Diseases Unit, Ospedali Riuniti, Reggio Calabria, Italy (C.Z.)
| | - Georgios Koutroumpas
- From the Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Greece (P.A.S., C.L., G.T., A.P., G.E.); Therapeutiki Hemodialysis Unit, Thessaloniki, Greece (A.K.); Hemodialysis Unit, Achillopouleion General Hospital, Volos, Greece (G.K., C.S.); Pieria Hemodialysis Unit, Katerini, Greece (V.R.); Section of Nephrology and Hypertension, 1st Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Greece (V.L.); Manhès Hospital and FCRIN INI-CRCTC, Fleury Mérogis, France (G.L.); and CNR-IFC, Clinical Epidemiology and Pathophysiology of Hypertension and Renal Diseases Unit, Ospedali Riuniti, Reggio Calabria, Italy (C.Z.)
| | - Vasilios Raptis
- From the Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Greece (P.A.S., C.L., G.T., A.P., G.E.); Therapeutiki Hemodialysis Unit, Thessaloniki, Greece (A.K.); Hemodialysis Unit, Achillopouleion General Hospital, Volos, Greece (G.K., C.S.); Pieria Hemodialysis Unit, Katerini, Greece (V.R.); Section of Nephrology and Hypertension, 1st Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Greece (V.L.); Manhès Hospital and FCRIN INI-CRCTC, Fleury Mérogis, France (G.L.); and CNR-IFC, Clinical Epidemiology and Pathophysiology of Hypertension and Renal Diseases Unit, Ospedali Riuniti, Reggio Calabria, Italy (C.Z.)
| | - Christos Syrgkanis
- From the Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Greece (P.A.S., C.L., G.T., A.P., G.E.); Therapeutiki Hemodialysis Unit, Thessaloniki, Greece (A.K.); Hemodialysis Unit, Achillopouleion General Hospital, Volos, Greece (G.K., C.S.); Pieria Hemodialysis Unit, Katerini, Greece (V.R.); Section of Nephrology and Hypertension, 1st Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Greece (V.L.); Manhès Hospital and FCRIN INI-CRCTC, Fleury Mérogis, France (G.L.); and CNR-IFC, Clinical Epidemiology and Pathophysiology of Hypertension and Renal Diseases Unit, Ospedali Riuniti, Reggio Calabria, Italy (C.Z.)
| | - Vasilios Liakopoulos
- From the Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Greece (P.A.S., C.L., G.T., A.P., G.E.); Therapeutiki Hemodialysis Unit, Thessaloniki, Greece (A.K.); Hemodialysis Unit, Achillopouleion General Hospital, Volos, Greece (G.K., C.S.); Pieria Hemodialysis Unit, Katerini, Greece (V.R.); Section of Nephrology and Hypertension, 1st Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Greece (V.L.); Manhès Hospital and FCRIN INI-CRCTC, Fleury Mérogis, France (G.L.); and CNR-IFC, Clinical Epidemiology and Pathophysiology of Hypertension and Renal Diseases Unit, Ospedali Riuniti, Reggio Calabria, Italy (C.Z.)
| | - Georgios Efstratiadis
- From the Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Greece (P.A.S., C.L., G.T., A.P., G.E.); Therapeutiki Hemodialysis Unit, Thessaloniki, Greece (A.K.); Hemodialysis Unit, Achillopouleion General Hospital, Volos, Greece (G.K., C.S.); Pieria Hemodialysis Unit, Katerini, Greece (V.R.); Section of Nephrology and Hypertension, 1st Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Greece (V.L.); Manhès Hospital and FCRIN INI-CRCTC, Fleury Mérogis, France (G.L.); and CNR-IFC, Clinical Epidemiology and Pathophysiology of Hypertension and Renal Diseases Unit, Ospedali Riuniti, Reggio Calabria, Italy (C.Z.)
| | - Gérard London
- From the Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Greece (P.A.S., C.L., G.T., A.P., G.E.); Therapeutiki Hemodialysis Unit, Thessaloniki, Greece (A.K.); Hemodialysis Unit, Achillopouleion General Hospital, Volos, Greece (G.K., C.S.); Pieria Hemodialysis Unit, Katerini, Greece (V.R.); Section of Nephrology and Hypertension, 1st Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Greece (V.L.); Manhès Hospital and FCRIN INI-CRCTC, Fleury Mérogis, France (G.L.); and CNR-IFC, Clinical Epidemiology and Pathophysiology of Hypertension and Renal Diseases Unit, Ospedali Riuniti, Reggio Calabria, Italy (C.Z.)
| | - Carmine Zoccali
- From the Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Greece (P.A.S., C.L., G.T., A.P., G.E.); Therapeutiki Hemodialysis Unit, Thessaloniki, Greece (A.K.); Hemodialysis Unit, Achillopouleion General Hospital, Volos, Greece (G.K., C.S.); Pieria Hemodialysis Unit, Katerini, Greece (V.R.); Section of Nephrology and Hypertension, 1st Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Greece (V.L.); Manhès Hospital and FCRIN INI-CRCTC, Fleury Mérogis, France (G.L.); and CNR-IFC, Clinical Epidemiology and Pathophysiology of Hypertension and Renal Diseases Unit, Ospedali Riuniti, Reggio Calabria, Italy (C.Z.)
| |
Collapse
|